Is Curative Biotechnology, Inc. (CUBT) a Buy, Sell, or Hold?
OTC : CUBT
Curative Biotechnology, Inc.
$1.125 USD
-$0.04 (-3.85%)
- Volume
- 100
- Average Volume
- 1.49K
- Market Capitalization
- $7.67M
- P/E Ratio
- -3.17
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.99
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.01
Company Overview
OTC
I. Richard Garr
Biotechnology
Healthcare
CUBT
4
US
USD
Liquidity Metrics
-0.22
0.01
0.01
0.01
0.00
Sales & Valuation
-$
0.00
-1.32
-8.75
-0.12
Profitability
-$0.003
-$2.26M
0.00%
0.00%
36.18%
-103.16%
P/E Metrics
-3.17
-0.06
-0.06
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
-37.46
1/9
-$8.27M
$2.07M
$8.37M
-$1.53M
Key Metrics (TTM)
$9.01M
0.00
-6.26
0.01
36.18%
31.11%
-25.75%
-11.43%
0 days
Company Executives
| Name | Title |
|---|---|
| Ronald Bordens | Executive Vice President of Process Product Drug Development and Member of Scientific & Clinical Advisory Board |
| Paul Michaels | President & Executive Chairman |
| I. Richard Garr | Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer & General Counsel |
| Pam Bisikirski | Vice President of Communications |
Poll Results
No votes yet today — be the first to share your view!
About Curative Biotechnology, Inc. (OTC:CUBT) Stock
Curative Biotechnology, Inc. is an emerging biomedical firm primarily focused on developing pharmaceutical products. Its research and development efforts are concentrated on a diverse pipeline targeting critical therapeutic areas, including infectious diseases, cancer, and vision-impairing degenerative eye conditions. Among its key pipeline assets is IMT504, an innovative immunotherapy designed for rabies treatment and as a vaccine enhancer. Another prominent candidate is CUBT906, a fully humanized CD56 monoclonal antibody that delivers a pyrrolobenzodiazepine dimer directly to tumor cells, aiming to eradicate them by halting their growth and spread. Additionally, the company is advancing a reformulated Metformin for the management of degenerative eye disorders. Curative Biotechnology has ... entered into a licensing and co-development partnership with Mid-Atlantic BioTherapeutics, Inc. to further advance IMT504, specifically for addressing advanced rabies and as a component of a COVID-19 vaccine. Previously known as Connectyx Technologies Holdings Group, Inc., the company adopted its current name, Curative Biotechnology, Inc., in November 2020. Established in 1995, the company maintains its headquarters in Boca Raton, Florida.
Frequently Asked Questions
-
What is the current Curative Biotechnology, Inc. (CUBT) stock price?
-
Curative Biotechnology, Inc.(OTC:CUBT) stock price is $1.125 in the last trading session. During the trading session, CUBT stock reached the peak price of $1.99 while $0.031 was the lowest point it dropped to. The percentage change in CUBT stock occurred in the recent session was --3.85% while the dollar amount for the price change in CUBT stock was -$0.04.
-
CUBT's industry and sector of operation?
-
The OTC listed CUBT is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of CUBT?
-
Ronald Bordens | Executive Vice President of Process Product Drug Development and Member of Scientific & Clinical Advisory Board
Paul Michaels | President & Executive Chairman
I. Richard Garr | Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer & General Counsel
Pam Bisikirski | Vice President of Communications
| -
How many employees does CUBT have?
-
Number of CUBT employees currently stands at 4. CUBT operates from 3801 PGA Blvd Suite 600, Palm Beach Gardens, FL 33410, US.
-
Link for CUBT official website?
-
Official Website of CUBT is: https://curativebiotech.com
-
How do I contact CUBT?
-
CUBT could be contacted at phone #561-907-8990 and can also be accessed through its website. CUBT operates from 3801 PGA Blvd Suite 600, Palm Beach Gardens, FL 33410, US.
-
How many shares of CUBT are traded daily?
-
The average number of CUBT shares traded daily for last 3 months was 1.49K.
-
What is the market cap of CUBT currently?
-
The market value of CUBT currently stands at $7.67M with its latest stock price at $1.125